multiple ascending dose
Showing 1 - 25 of >10,000
Alopecia Areata Trial in Randwick (OR-101 (Single ascending dose), OR-101 (Food effect), OR-101 (Multiple ascending dose))
Not yet recruiting
- Alopecia Areata
- OR-101 (Single ascending dose)
- +3 more
-
Randwick, New South Wales, AustraliaSCIENTIA Clinical Research Ltd
Sep 13, 2023
Healthy Volunteers Trial in Copenhagen (AP31969, Placebo)
Not yet recruiting
- Healthy Volunteers
- AP31969
- Placebo
-
Copenhagen, DenmarkAcesion Pharma
Sep 27, 2023
Cocaine Use Disorder, Substance Use Disorders, Healthy Volunteers Trial in Overland Park (TMP-301, Placebo)
Active, not recruiting
- Cocaine Use Disorder
- +2 more
- TMP-301
- Placebo
-
Overland Park, KansasAltasciences
Aug 29, 2023
Healthy Volunteers Trial in Miami (CRN04894 Oral Solution, Placebo Oral Solution)
Completed
- Healthy Volunteers
- CRN04894 Oral Solution
- Placebo Oral Solution
-
Miami, FloridaQPS-Miami Research Associates
Sep 19, 2023
Healthy Participants Trial in Tempe (CK-4021586, Placebo for CK-4021586)
Recruiting
- Healthy Participants
- CK-4021586
- Placebo for CK-4021586
-
Tempe, ArizonaCelerion
May 17, 2023
Healthy Trial in Christchurch (LTG-001, Placebo)
Not yet recruiting
- Healthy
- LTG-001
- Placebo
-
Christchurch, New ZealandClinical Research Unit
Sep 21, 2023
Muscle Spasticity, Hypertonia, Muscle, Cerebral Palsy Trial in San Antonio (MTR-601)
Recruiting
- Muscle Spasticity
- +7 more
-
San Antonio, TexasWorldwide Clinical Trials
Oct 31, 2023
Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Ivaltinostat
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 6, 2023
Myocardial Infarction Trial in Adelaide (NP-011 (Single Ascending Dose Phase), NP-011 (Multiple Ascending Dose Phase), NP-011
Recruiting
- Myocardial Infarction
- NP-011 (Single Ascending Dose Phase)
- +2 more
-
Adelaide, South Australia, AustraliaCMAX Clinical Research Pty Ltd
Sep 26, 2022
Healthy Participants Trial in Dallas (CK-3828136, Placebo for CK-3828136)
Recruiting
- Healthy Participants
- CK-3828136
- Placebo for CK-3828136
-
Dallas, TexasLabcorp Clinical Research Unit Inc.
Dec 20, 2022
Alzheimer's Disease Trial in San Antonio (PU-AD, Placebo)
Completed
- Alzheimer's Disease
- PU-AD
- Placebo
-
San Antonio, TexasICON Early Phase Services
Nov 14, 2022
Healthy Volunteers Trial in Shanghai (JS1-1-01, Placebo)
Recruiting
- Healthy Volunteers
- JS1-1-01
- Placebo
-
Shanghai, ChinaShanghai Mental Health Center
Dec 16, 2022
MDD Trial in Rogers (apimostinel, Placebo)
Recruiting
- Major Depressive Disorder
- apimostinel
- Placebo
-
Rogers, ArkansasWoodland Research Northwest
Oct 27, 2022
Healthy Participants Trial in Glendale (AZD2389, Placebo)
Not yet recruiting
- Healthy Participants
- AZD2389
- Placebo
-
Glendale, CaliforniaResearch Site
Nov 14, 2023
Psoriasis, Atopic Dermatitis Trial in United States (XmAb27564, Placebo)
Recruiting
- Psoriasis
- Atopic Dermatitis
- XmAb27564
- Placebo
-
Thousand Oaks, California
- +3 more
Aug 22, 2023
Healthy Subjects Trial in Christchurch (EC5026 oral tablet, Placebo oral tablet)
Not yet recruiting
- Healthy Subjects
- EC5026 oral tablet
- Placebo oral tablet
-
Christchurch, New ZealandNew Zealand Clinical Research
Oct 17, 2023
Kidney Disease Trial run by the NIDDK (N-acetyl D-mannosamine)
Completed
- Kidney Disease
- N-acetyl D-mannosamine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 26, 2023
Parkinson Disease Trial in Nottingham (NM-101, Placebo)
Not yet recruiting
- Parkinson Disease
- NM-101
- Placebo
-
Nottingham, United KingdomQuotient Sciences
Mar 16, 2023